Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 944,347 |
|
|||||
| News | - | ||||||
| Day High | 12.58 | Low High |
|||||
| Day Low | 10.85 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ambrx Biopharma Inc | AMAM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.49 | 4.25% | 12.03 | 18:19:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.69 | 10.85 | 12.58 | 12.38 | 11.54 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,765 | 944,347 | $ 11.95 | $ 11,284,255 | - | 6.55 - 16.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:19:33 | formt | 217 | $ 12.03 | USD |
Ambrx Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 771.74M | 62.54M | - | 7.4M | -78M | -1.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ambrx Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMAM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.48 | 13.22 | 9.25 | 11.24 | 1,313,621 | 2.55 | 26.9% |
| 1 Month | 10.84 | 13.22 | 7.99 | 10.36 | 754,522 | 1.19 | 10.98% |
| 3 Months | 12.74 | 16.285 | 6.55 | 10.47 | 1,036,881 | -0.71 | -5.57% |
| 6 Months | 14.69 | 16.86 | 6.55 | 11.53 | 653,022 | -2.66 | -18.11% |
| 1 Year | 10.74 | 16.86 | 6.55 | 11.50 | 624,852 | 1.29 | 12.01% |
| 3 Years | 10.74 | 16.86 | 6.55 | 11.50 | 624,852 | 1.29 | 12.01% |
| 5 Years | 10.74 | 16.86 | 6.55 | 11.50 | 624,852 | 1.29 | 12.01% |
Ambrx Biopharma Description
| Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code technology platform that allows incorporating synthetic amino acids (SAAs) into proteins within living cells. Its product pipeline includes ARX788, ARX517, ARX305 among others. |
